{"gene":"HOXA1","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":1993,"finding":"Hoxa1 null mice display loss of rhombomeres 4 and 5, absence of facial and abducens motor neurons, and abnormal neural crest migration, establishing Hoxa1 as required for specification of rhombomere identity in the developing hindbrain.","method":"Targeted gene knockout in mice with 3D reconstructions, histological analysis, and whole-mount anti-neurofilament immunostaining","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal knockout phenotype replicated by two independent labs (PMID:8287791 and PMID:7903632) with multiple morphological and molecular readouts","pmids":["8287791","7903632"],"is_preprint":false},{"year":1993,"finding":"In Hoxa1 null mice, the expression of Krox-20, int-2/fgf-3, and Hoxb1 is aberrant, indicating that Hoxa1 is required upstream of these rhombomere-identity genes and for proper specification of r3–r8 cell identity and/or cell migration.","method":"In situ hybridization and carbocyanine dye injection tract tracing in Hoxa1 null mice","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function with defined molecular readout, replicated across independent knockout lines","pmids":["7903632"],"is_preprint":false},{"year":1993,"finding":"RAR-gamma mediates retinoic acid induction of Hoxa1 in F9 embryonal carcinoma cells; targeted disruption of RARgamma abolishes RA-induced Hoxa1 expression, establishing RARgamma as the primary receptor mediating this response in this cell context.","method":"Gene disruption of both RARgamma alleles in F9 cells followed by RA treatment and gene expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined molecular phenotype, further confirmed by RAR-type-specific synthetic retinoids in PMID:8650243","pmids":["8105479","8650243"],"is_preprint":false},{"year":1995,"finding":"A retinoic acid response element (RARE) within the Hoxa1 3' enhancer is required for expression in neuroepithelium caudal to rhombomere 4; point mutations in the RARE abolish this expression domain in transgenic mice, demonstrating direct RA-mediated transcriptional control of Hoxa1.","method":"Transgenic mouse reporter assays with point mutations in the RARE; in vivo enhancer analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis of a cis-regulatory element with functional in vivo validation, replicated in PMID:9053316","pmids":["7743939","9053316"],"is_preprint":false},{"year":1997,"finding":"Mutation of the Hoxa1 3' RARE by Cre-loxP targeting reduces early Hoxa1 expression boundary establishment, causing rhombomere and cranial nerve abnormalities similar to (but milder than) the Hoxa1 total knockout, and abolishes correct Hoxa2 expression in rhombomere 5, demonstrating that this RARE directly mediates RA-driven Hoxa1 patterning function.","method":"Cre-loxP targeted mutation of the 3'RARE in mice; phenotypic analysis of neural and cranial structures","journal":"Development","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vivo mutagenesis of specific cis element with orthogonal phenotypic and molecular readouts","pmids":["9053316"],"is_preprint":false},{"year":1994,"finding":"Ectopic widespread expression of Hoxa1 in transgenic mice induces ectopic Hoxb1 expression in rhombomere 2 and transforms select hindbrain regions toward rhombomere-4-like identity, demonstrating that Hoxa1 functions as a transcriptional regulator of Hoxb1 and a determinant of rhombomere identity.","method":"Beta-actin promoter-driven Hoxa1 transgenic mice with in situ hybridization; dual-transgenic reporter assay with Hoxb1/lacZ","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain-of-function transgenic with dual reporter validation and multiple molecular readouts","pmids":["7956823"],"is_preprint":false},{"year":1996,"finding":"Overexpression of Hoxa1 mRNA in zebrafish phenocopies retinoic acid treatment, causing anterior hindbrain abnormalities, duplication of Mauthner neurons in r2, and fate changes in r2 neural crest, establishing Hoxa1 as a mediator of RA-induced anterior hindbrain patterning.","method":"Synthetic RNA injection into fertilized zebrafish eggs; exogenous RA treatment with in situ hybridization","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function in a vertebrate model with defined phenotypic readout; single lab","pmids":["8631251"],"is_preprint":false},{"year":1998,"finding":"HOXA1 (and HOXB1), together with Pbx1, bind to Hox-Pbx consensus sites in the EphA2 (Eck) enhancer and co-expression of HOXA1 or HOXB1 with Pbx1 transactivates EphA2 enhancer-dependent reporter expression in vitro; EphA2 expression is reduced in hoxa1/hoxb1 double mutant mice, establishing EphA2 as a direct transcriptional target of Hoxa1 in rhombomere 4.","method":"In vitro DNA binding assays (EMSA), reporter gene transactivation assays, transgenic mouse enhancer analysis, and analysis of double-mutant mice","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro binding + transactivation + in vivo genetic validation with multiple orthogonal methods in single study","pmids":["9733765"],"is_preprint":false},{"year":1998,"finding":"Genetic analysis of Hoxa1/Hoxb1 double-null mice reveals that both genes cooperate to establish and maintain Hoxb1 expression in rhombomere 4 via auto- and para-regulatory interactions, and that the EphA2 r4 marker fails to activate in double mutants, indicating that Hoxa1 and Hoxb1 are required to initiate r4 specification.","method":"Genetic double-mutant analysis; in situ hybridization for rhombomere markers including Eph receptors","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with molecular marker readouts, replicated across two independent papers (PMID:9463349, PMID:9463359)","pmids":["9463349","9463359"],"is_preprint":false},{"year":1998,"finding":"The YPWM hexapeptide motif of HOXA1 is strictly required for cooperative DNA binding with PBX1 in vitro and for cooperative interaction in vivo; the GKFQ domain of PBX increases DNA binding by PBX but is not the primary contact for the HOXA1 YPWM motif; the YPWM motif contacts the PBX homeodomain.","method":"In vitro binding assays (EMSA), reporter gene assays, truncated and mutant PBX/HOX protein analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro binding with mutagenesis and in vivo reporter validation in single study","pmids":["9582372"],"is_preprint":false},{"year":1998,"finding":"Hoxa1 and Hoxb1 synergize in patterning the facial (VII) through accessory (XI) cranial nerves and the second pharyngeal arch; combined loss results in involution of the second arch by E10.5, complete loss of second arch-derived structures, and external/middle ear development disruption, revealing extensive functional synergy not apparent from single mutants.","method":"Compound Hoxa1/Hoxb1 null mouse mutant analysis; neurofilament staining; retrograde motor neuron labeling; neural crest marker analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis in compound mutants with multiple orthogonal morphological and molecular readouts, replicated across labs","pmids":["9463359","10529420"],"is_preprint":false},{"year":2001,"finding":"HOXB1 has significantly higher transcriptional activity than its paralog HOXA1 on the Hoxb1 auto-regulatory enhancer (b1-ARE) in embryonal carcinoma cells; this differential activity maps to the N-terminal transcriptional activation domain of HOXB1; in vivo, Hoxa1 is the primary mediator of the RA response at the b1-ARE in a SOX/OCT heterodimer-dependent manner.","method":"Reporter gene assays in embryonal carcinoma cells; domain-swap analysis; transgenic mouse analysis with SOX/OCT site mutations; Hoxa1 mutant mice","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reporter assay with domain mapping plus in vivo transgenic and mutant mouse validation in single study","pmids":["11278854"],"is_preprint":false},{"year":2001,"finding":"Loss of Hoxa1 results in reduction of rhombomere 4 size and loss of its ability to generate neural crest cells, demonstrated to be cell-autonomous by grafting wild-type cells into double-mutant mouse embryo cultures.","method":"Ectoderm-specific Hoxb1 regulatory mutation combined with Hoxa1 null; molecular/lineage analysis; in vitro grafting experiments","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — cell-autonomous demonstration by grafting plus molecular marker analysis in single study","pmids":["11532923"],"is_preprint":false},{"year":2001,"finding":"In Hoxa1 null mice, ectopic neuronal groups originating from misspecified r3-r4 levels escape apoptosis, establish a supernumerary neuronal circuit with r2 identity, and become functionally integrated into the respiratory rhythm-generating network postnatally, demonstrating that Hoxa1 normally represses this alternate neural circuit.","method":"Electrophysiological recording, anatomical analysis, molecular identity marker expression in Hoxa1 null mice","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with electrophysiological and molecular readouts, single lab","pmids":["11466434"],"is_preprint":false},{"year":2002,"finding":"Homeodomain residues 2 and 3 (Asn and Ala) of Hoxa1 determine its functional specificity on the somatostatin TSEII enhancer as a monomer, but do not affect activity in HOXA1-Pbx1 heterodimers; on the Hoxb1 b1-ARE, these residues can modulate activity in a cell-type dependent manner even in the presence of Pbx.","method":"Site-directed mutagenesis of homeodomain residues; reporter gene transactivation assays in multiple cell lines with defined cofactors","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — mutagenesis combined with reporter assays; single lab, cell-based only","pmids":["12060683"],"is_preprint":false},{"year":2002,"finding":"Hoxa1 is required upstream of several genes regulating cardiac neural crest cell specification; Hoxa1 null mice exhibit cardiovascular malformations (interrupted aortic arch, aberrant subclavian artery, Tetralogy of Fallot), and lineage tracing shows Hoxa1 is expressed in cardiac NCC precursors.","method":"Hoxa1-IRES-Cre lineage tracing; Hoxa1 null mouse cardiovascular phenotyping; molecular marker analysis for NCC specification genes","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — lineage tracing combined with loss-of-function phenotyping and upstream/downstream gene analysis; replicated in human syndrome (PMID:16155570)","pmids":["21940751","20171203"],"is_preprint":false},{"year":2002,"finding":"HOXA1 transcriptionally upregulates Bcl-2, promoting cell survival in human mammary carcinoma cells; forced HOXA1 expression also promotes anchorage-independent proliferation and induces oncogenic transformation of immortalized mammary epithelial cells in a Bcl-2-dependent manner.","method":"Forced expression and siRNA knockdown of HOXA1 in human mammary carcinoma cells; luciferase reporter assays; soft-agar colony formation; in vivo tumor formation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional rescue/inhibition with defined molecular target; single lab","pmids":["12482855"],"is_preprint":false},{"year":2005,"finding":"E-cadherin-dependent signaling via Rac1 increases HOXA1 expression at confluence in mammary carcinoma cells, and this HOXA1 upregulation is required for E-cadherin-dependent anchorage-independent proliferation and survival.","method":"E-cadherin function-blocking antibody, Ca2+ chelation with EGTA, Rac1 pathway analysis, HOXA1 forced expression and siRNA in MCF-7 cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple epistatic and pharmacological perturbations; single lab","pmids":["16373333"],"is_preprint":false},{"year":2007,"finding":"HOXA1-stimulated oncogenicity in human mammary carcinoma cells is mediated by transcriptional upregulation of GRB2, MEK1, and SDFR1, leading to increased p44/42 MAP kinase phosphorylation and activity; MEK1 inhibitor abolishes HOXA1-mediated proliferation, survival, and transformation.","method":"Microarray gene expression profiling; Western blot for phospho-MAPK; MEK1 inhibitor treatment; forced HOXA1 expression and siRNA knockdown","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional epistasis with pharmacological inhibitor and multiple molecular readouts; single lab","pmids":["17213808"],"is_preprint":false},{"year":2007,"finding":"RARgamma and RXRalpha are constitutively associated with the Hoxa1 RARE; upon RA treatment, pCIP, p300, and RNA Pol II increase at the Hoxa1 RARE while the PcG protein SUZ12 dissociates; H3K27me3 decreases while H3ac and H3K4me2 remain constant; upon RA removal, SUZ12 re-associates, revealing dynamic epigenetic regulation of Hoxa1 by RA signaling and PcG repression.","method":"Chromatin immunoprecipitation (ChIP) assays in F9 embryonal carcinoma cells for RAR, RXR, co-activators, Pol II, SUZ12, and histone modifications","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with multiple antibodies and time-points; single lab","pmids":["17663992"],"is_preprint":false},{"year":2008,"finding":"Hoxa1 is required for neuronal differentiation of ES cells along the neural lineage in response to RA; Hoxa1 null ES cells fail to express neuronal markers and instead upregulate endodermal markers; re-introduction of Hoxa1 rescues neuronal differentiation; Hoxa1 may act partly by inhibiting Sox17 expression.","method":"Hoxa1 null ES cell differentiation assay; RA-induced embryoid body protocol; re-expression of exogenous Hoxa1 under metallothionein promoter; Sox17 overexpression in WT ES cells","journal":"Journal of neuroscience research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function and rescue experiments with defined molecular readouts; single lab","pmids":["18512762"],"is_preprint":false},{"year":2011,"finding":"KDM3A (JMJD1A) activates HOXA1 transcription by demethylating histone H3K9me2 at the HOXA1 promoter; KDM3A knockdown decreases HOXA1 and CCND1 expression and causes G1 arrest; KDM3A and HOXA1 expression levels are statistically correlated in cancer cell lines and bladder cancer samples.","method":"siRNA knockdown of KDM3A; ChIP for H3K9me2 at HOXA1 promoter; gene expression analysis; cell proliferation assays","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating epigenetic writer activity at HOXA1 locus combined with functional siRNA; single lab","pmids":["22020899"],"is_preprint":false},{"year":2011,"finding":"Hoxa1 null microarray analysis identifies ~300 downstream targets in the r3-r5 hindbrain region; validated targets include neural crest specification genes Zic1, Hnf1b, Foxd3 (downregulated in cardiac NCC-generating hindbrain), and inner ear genes Pax8 and Fgfr3, establishing Hoxa1 as an upstream regulator in these developmental cascades.","method":"Microarray analysis on laser-microdissected r3-r5 tissue from Hoxa1 null vs. wild-type embryos; RT-PCR validation","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with validated gene expression changes in tissue-specific context; single lab","pmids":["21784065"],"is_preprint":false},{"year":2011,"finding":"Hoxa1 lineage tracing via Hoxa1-IRES-Cre reveals Hoxa1-expressing precursors contribute to rhombomere 3 (more anterior than previously reported), otic epithelium (excluding sensory patches), atria, and cardiac outflow tract, indicating a direct role for Hoxa1 in these tissues.","method":"Genetic lineage tracing using Hoxa1-IRES-Cre knock-in mouse line with Rosa26-reporter","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct genetic fate mapping with functional implications; single lab but rigorous method","pmids":["20171203"],"is_preprint":false},{"year":2011,"finding":"The Pbx-interaction hexapeptide (YPWM-containing) motif of Hoxa1 is essential for its oncogenic activity; a Hoxa1 mutant with substituted hexapeptide residues loses the ability to stimulate cell proliferation, anchorage-independent growth, and contact inhibition bypass.","method":"Site-directed mutagenesis of the hexapeptide; forced expression of wild-type vs. mutant Hoxa1 in mammary carcinoma cells; proliferation, soft-agar, and contact inhibition assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional mutagenesis with defined oncogenic phenotype readout; single lab","pmids":["21957483"],"is_preprint":false},{"year":2012,"finding":"A proteome-wide yeast two-hybrid screen and affinity co-purification identified 59 Hoxa1 interactors (45 confirmed by co-purification), including cell-signaling, cell-adhesion, and vesicular trafficking proteins; bimolecular fluorescence complementation revealed distinctive subcellular patterns (vesicular, cytoplasmic, or nuclear) for different interaction subsets.","method":"Yeast two-hybrid screening of ~12,200 ORF-derived polypeptides; affinity co-purification in animal cell lines; bimolecular fluorescence complementation","journal":"BMC developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic interactome screen confirmed by co-purification and BiFC; pan-interactome format but focused on this gene","pmids":["23088713"],"is_preprint":false},{"year":2012,"finding":"HOXA1 increases PRLR (prolactin receptor) mRNA and protein expression in MCF-7 cells; forced HOXA1 expression enhances prolactin-stimulated phosphorylation of STAT5A/B and p44/42 MAPK and enhances hPRL-stimulated cell proliferation and anchorage-independent growth, which is blocked by a PRLR antagonist, establishing PRLR as a functional downstream effector of HOXA1 oncogenicity.","method":"Forced HOXA1 expression in MCF-7 cells; PRLR mRNA/protein quantification; phosphorylation assays; PRLR antagonist; soft-agar growth assay","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — forced expression with pharmacological epistasis and multiple signaling readouts; single lab","pmids":["23064471"],"is_preprint":false},{"year":2014,"finding":"ACK1 tyrosine kinase phosphorylates the H3K9 demethylase KDM3A at Tyr-1114 in response to heregulin, decreasing H3K9me2 deposition and thereby activating HOXA1 transcription; ACK1 inhibition by AIM-100 or Dasatinib restores H3K9me2 marks and suppresses HOXA1 expression, even in tamoxifen-resistant conditions.","method":"Kinase assay demonstrating ACK1 phosphorylation of KDM3A; histone methylation ChIP; gene expression analysis; ACK1 small molecule inhibitors in breast cancer cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct kinase-substrate phosphorylation demonstrated with histone ChIP evidence and pharmacological validation; single lab but multiple orthogonal methods","pmids":["25148682"],"is_preprint":false},{"year":2015,"finding":"lncRNA HOTAIRM1 sequesters histone methyltransferases G9a (H3K9me2) and EZH2 (H3K27me3) and DNA methyltransferases (DNMT1, DNMT3b) away from the HOXA1 gene TSS, causing demethylation of H3K9 and H3K27 and reduced DNA methylation, thereby activating HOXA1 transcription in glioblastoma cells.","method":"Chromatin immunoprecipitation (ChIP); RNA-ChIP; bisulfite sequencing methylation analysis; siRNA knockdown of HOTAIRM1","journal":"Journal of experimental & clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and RNA-ChIP with multiple histone marks plus methylation sequencing; single lab","pmids":["30376874"],"is_preprint":false},{"year":2015,"finding":"YAP (Hippo pathway transcriptional co-activator) regulates Hoxa1 expression in dental/oral epithelium and skin epidermis; ChIP assay suggests YAP acts through TEAD transcription factors to activate Hoxa1; Hoxa1 is functionally involved in YAP-regulated epithelial progenitor cell proliferation by sphere formation assay.","method":"Yap conditional knockout and YAP transgenic mice; RNA-Seq; ChIP for YAP/TEAD; sphere formation assay; in situ hybridization","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss/gain-of-function with ChIP and functional proliferation assay; single lab","pmids":["25691658"],"is_preprint":false},{"year":2016,"finding":"HOXA1 binds RBCK1/HOIL-1 and TRAF2 (TNF receptor-associated proteins) via its 11-histidine repeat and homeodomain; HOXA1 activates NF-κB in a non-transcriptional manner, acting upstream of the NF-κB inhibitor IκB; epistasis experiments show RBCK1 and TRAF2 effects on NF-κB are epistatic to HOXA1; NF-κB activation is required for HOXA1 oncogenic activity.","method":"Proteome-wide interaction screening; co-immunoprecipitation; reporter assays for NF-κB activity; domain-deletion mutagenesis; epistasis analysis with RBCK1/TRAF2 knockdown","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — interaction confirmed by Co-IP, functional epistasis, mutagenesis, and non-transcriptional mechanism established; single lab but multiple orthogonal methods","pmids":["27382069"],"is_preprint":false},{"year":2017,"finding":"Genome-wide Hoxa1 ChIP-seq in RA-differentiated ES cells reveals dynamic binding to pluripotency regulatory targets; Hoxa1 co-occupies many sites with Nanog, including the Nanog promoter itself; Nanog binds a 3' enhancer of Hoxa1; mutual repression between Hoxa1 and Nanog provides a molecular switch between pluripotency and differentiation. Hoxa1 also binds regulatory regions of Sox2, Esrrb, and Myc.","method":"Genome-wide ChIP-seq for Hoxa1 and Nanog in RA-treated ES cells; gene expression analysis at multiple differentiation time-points","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide binding data with reciprocal cross-regulatory validated binding; multiple targets confirmed; single lab but rigorous methods","pmids":["28584089"],"is_preprint":false},{"year":2017,"finding":"Genome-wide Hoxa1 ChIP-seq combined with differential gene expression in Hoxa1 gain- and loss-of-function mouse/zebrafish embryos identifies Hoxa1 as a regulator of multiple developmental signaling pathways (Wnt, TGF-β, Hedgehog, Hippo) by targeting multiple components within each pathway; two validated enhancers (in Dok5 and Wls1) mediate neural expression in vivo.","method":"Hoxa1 ChIP-seq in RA-differentiated mouse ES cells; microarray differential expression in Hoxa1 gain/loss-of-function mouse and zebrafish; in vivo transgenic enhancer reporter assays","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq plus gain/loss-of-function transcriptomics in two species plus in vivo enhancer validation; single lab but highly rigorous multi-modal approach","pmids":["28982536"],"is_preprint":false},{"year":2017,"finding":"KDM3B binds to the retinoic acid response element (RARE) of the HOXA1 gene (but not its promoter) and regulates HOXA1 expression; KDM3B knockdown increases H3K9me1 but decreases H3K9me2 at the RARE, modulating HOXA1 transcription in AML cells.","method":"ChIP for KDM3B and histone marks (H3K9me1, H3K9me2) at HOXA1 RARE; siRNA knockdown; Western blot; real-time PCR","journal":"Leukemia & lymphoma","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating histone demethylase binding at specific HOXA1 regulatory element; single lab","pmids":["28540746"],"is_preprint":false},{"year":2019,"finding":"A distal enhancer ~450 kb from the Hoxa1 locus interacts with the Hoxa1 promoter via a long-range chromatin loop; deletion of this enhancer significantly inhibits RA-induced Hoxa1 expression and blocks early ES cell differentiation; restoration of Hoxa1 expression rescues ~40% of differentially expressed genes, and ~18% of rescued gene promoters are directly bound by Hoxa1.","method":"CRISPR/Cas9 enhancer deletion; 3C/chromatin loop analysis; transcriptome analysis; ChIP for Hoxa1 binding at rescued gene promoters","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — enhancer deletion with chromatin loop demonstration, rescue experiments, and direct Hoxa1 ChIP; single lab but multiple orthogonal methods","pmids":["31147716"],"is_preprint":false},{"year":2020,"finding":"lncRNA HOTAIRM1 prevents PRC2 complex (EZH2/SUZ12) binding at the HOXA1 promoter, inhibiting H3K27me3 deposition and thereby maintaining HOXA1 expression; HOTAIRM1 knockdown increases H3K27me3 at the HOXA1 promoter and reduces HOXA1 expression in tamoxifen-resistant MCF-7 cells.","method":"ChIP for EZH2, SUZ12, and H3K27me3 at HOXA1 promoter; HOTAIRM1 knockdown; RNA-immunoprecipitation for HOTAIRM1-EZH2 interaction","journal":"Journal of Cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with lncRNA knockdown demonstrating epigenetic mechanism; single lab","pmids":["32284737"],"is_preprint":false},{"year":2023,"finding":"HOXA1 transcriptionally activates NF-κB RelA (p65) and KLF4 in vascular smooth muscle cells (VSMCs), promoting lipid accumulation, VSMC-to-macrophage phenotypic switching, and inflammation; HOXA1 knockdown via AAV1-shHOXA1 reduces atherosclerotic plaque formation in ApoE-/- mice.","method":"AAV-mediated shRNA knockdown of HOXA1 in ApoE-/- atherosclerosis mice; in vitro POV-PC-treated VSMC model; Western blot; ChIP for HOXA1 at RelA and KLF4 promoters","journal":"Molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo loss-of-function with ChIP demonstrating direct transcriptional targets; single lab","pmids":["37528397"],"is_preprint":false},{"year":2023,"finding":"HOXA1 directly regulates the transcriptional activity of ENO1 and PGK1 (glycolytic enzymes), promoting aerobic glycolysis and cancer progression in cervical cancer cells; HOXA1 knockdown reduces glycolysis and tumor growth in vivo.","method":"Luciferase reporter assays with ENO1/PGK1 promoters; HOXA1 overexpression and knockdown in cervical cancer cells; in vivo xenograft model with glycolysis metabolite measurement","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay for direct transcriptional targets with in vivo validation; single lab","pmids":["37286120"],"is_preprint":false},{"year":2015,"finding":"HOTAIR lncRNA promotes chemoresistance in SCLC by recruiting DNMT1 and DNMT3b to methylate the HOXA1 gene promoter; HOTAIR knockdown reduces HOXA1 methylation and restores HOXA1 expression; RNA immunoprecipitation confirmed a direct interaction between HOTAIR RNA and HOXA1 locus.","method":"Bisulfite sequencing PCR; Western blot for DNMTs; RNA immunoprecipitation; HOTAIR siRNA knockdown in resistant SCLC cells","journal":"Laboratory investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNA-ChIP and bisulfite sequencing establish epigenetic mechanism; single lab","pmids":["26707824"],"is_preprint":false},{"year":2005,"finding":"Polyhistidine tract expansions in HOXA1 isoform A (11 and 12 histidines) cause protein aggregation in the nucleus and increased cell death compared to normal (10) or shorter variants; aggregates are ubiquitinated and inhibited by the histidine-modifying compound DEPC.","method":"Forced expression of HOXA1 polyhistidine variants in COS-7 and SK-N-SH cells; immunofluorescence for aggregation; DEPC treatment; cell viability assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct expression of protein variants with morphological and functional readouts; single lab","pmids":["16168961"],"is_preprint":false}],"current_model":"HOXA1 is a homeodomain transcription factor that, via its YPWM hexapeptide motif and cooperative binding with PBX1 cofactors, directly activates target genes (including EphA2, Hoxb1, ENO1, PGK1, Bcl-2, PRLR, RelA, KLF4) to control hindbrain rhombomere identity, neural crest generation and migration, inner ear and cardiovascular development, and—in pathological contexts—oncogenic transformation; its expression is directly induced by retinoic acid through RARgamma/RXRalpha binding to a 3' RARE and modulated epigenetically by KDM3A-mediated H3K9me2 demethylation (activated by ACK1 phosphorylation) and PRC2/SUZ12-mediated H3K27me3, while in the nucleus it also engages non-transcriptional signaling through RBCK1/HOIL-1 and TRAF2 to activate NF-κB upstream of IκB."},"narrative":{"mechanistic_narrative":"HOXA1 is a homeodomain transcription factor that acts at the top of the developmental cascade specifying hindbrain rhombomere identity, in which its loss eliminates rhombomeres 4 and 5, abolishes facial and abducens motor neurons, and disrupts neural crest migration [PMID:8287791, PMID:7903632]. It establishes rhombomere identity by directly regulating the rhombomere-patterning gene network, initiating and maintaining Hoxb1 expression in rhombomere 4 through auto- and para-regulatory interactions and activating the r4 marker EphA2/Eck by binding Hox-Pbx consensus sites cooperatively with PBX1 [PMID:7956823, PMID:9733765, PMID:9463349, PMID:9463359]. This cooperative DNA binding requires the YPWM hexapeptide motif, which contacts the PBX homeodomain [PMID:9582372]. HOXA1 expression is itself a direct retinoic acid response: RARgamma mediates RA induction [PMID:8105479, PMID:8650243], and a 3' RARE drives correct caudal and boundary expression in vivo, with mutation of this element phenocopying a partial knockout [PMID:7743939, PMID:9053316]. Beyond its r4-specifying role, HOXA1 is required cell-autonomously for neural crest generation, cardiac neural crest specification and cardiovascular morphogenesis, inner ear development, and RA-driven neuronal differentiation of ES cells, governing target cascades that include Zic1, Hnf1b, Foxd3, Pax8, and Fgfr3 [PMID:11532923, PMID:21940751, PMID:20171203, PMID:18512762, PMID:21784065]. Genome-wide binding studies show HOXA1 reciprocally cross-regulates the pluripotency factor Nanog and targets multiple components of the Wnt, TGF-beta, Hedgehog, and Hippo pathways, functioning as a switch between pluripotency and differentiation [PMID:28584089, PMID:28982536]. In pathological contexts HOXA1 acts as an oncogene: it transcriptionally upregulates Bcl-2, PRLR, and glycolytic enzymes ENO1 and PGK1, drives GRB2/MEK1-dependent MAPK signaling, and engages a non-transcriptional route through RBCK1/HOIL-1 and TRAF2 to activate NF-kappaB upstream of IkappaB, with both the YPWM motif and NF-kappaB activation required for transformation [PMID:12482855, PMID:21957483, PMID:23064471, PMID:27382069, PMID:37286120]. Its locus is heavily controlled by chromatin and epigenetic inputs, including KDM3A/KDM3B H3K9 demethylation (the former activated by ACK1 phosphorylation), PRC2/SUZ12 H3K27me3, lncRNA-directed methylation, and a distal enhancer engaged through long-range chromatin looping [PMID:17663992, PMID:22020899, PMID:25148682, PMID:31147716].","teleology":[{"year":1993,"claim":"Established the core developmental requirement for HOXA1 by showing it is needed to build the posterior hindbrain, defining the process the gene controls.","evidence":"Targeted knockout in mice with 3D reconstruction and neurofilament immunostaining, plus in situ analysis of downstream patterning genes","pmids":["8287791","7903632"],"confidence":"High","gaps":["Did not identify the direct transcriptional targets responsible for r4/r5 loss","Did not distinguish cell-autonomous from non-autonomous effects"]},{"year":1993,"claim":"Identified RARgamma and a 3' RARE as the upstream signal driving HOXA1, answering how positional retinoic acid information is converted into Hoxa1 transcription.","evidence":"RARgamma allelic disruption in F9 cells and transgenic reporter/Cre-loxP mutagenesis of the 3' RARE in mice","pmids":["8105479","7743939","9053316"],"confidence":"High","gaps":["Additional enhancers beyond the 3' RARE not fully mapped at this stage","Did not address chromatin context of RARE activation"]},{"year":1994,"claim":"Demonstrated HOXA1 acts as a transcriptional determinant of rhombomere identity by showing ectopic expression imposes r4-like fate and induces Hoxb1.","evidence":"Gain-of-function transgenic mice with Hoxb1/lacZ dual reporter and in situ hybridization, with zebrafish RNA injection phenocopying RA","pmids":["7956823","8631251"],"confidence":"High","gaps":["Did not show direct binding of HOXA1 to the Hoxb1 enhancer","Mechanism of fate transformation not resolved"]},{"year":1998,"claim":"Defined the molecular logic of HOXA1 target activation, showing cooperative PBX1 binding via the YPWM motif and direct regulation of EphA2 and Hoxb1 in r4.","evidence":"EMSA, reporter transactivation, hexapeptide/homeodomain mutagenesis, transgenic enhancer assays and Hoxa1/Hoxb1 double-mutant analysis","pmids":["9733765","9463349","9463359","9582372"],"confidence":"High","gaps":["Genome-wide direct target repertoire still unknown at this stage","Did not establish how monomer vs heterodimer binding choices are made in vivo"]},{"year":2001,"claim":"Refined HOXA1 functional specificity by mapping activity to homeodomain residues and the N-terminal activation domain and showing cell-autonomous requirement for neural crest generation.","evidence":"Domain-swap and homeodomain mutagenesis reporter assays, SOX/OCT site transgenics, and wild-type cell grafting into double-mutant embryos","pmids":["11278854","12060683","11532923","11466434"],"confidence":"High","gaps":["How HOXA1 and HOXB1 achieve distinct activities in vivo despite shared targets","Mechanism of apoptotic/circuit repression in null mice not molecularly defined"]},{"year":2002,"claim":"Extended HOXA1 function to cardiovascular and broader developmental programs and uncovered its oncogenic activity through Bcl-2-mediated survival.","evidence":"Hoxa1-IRES-Cre lineage tracing and null cardiovascular phenotyping; forced expression/siRNA and soft-agar transformation in mammary cells","pmids":["21940751","20171203","12482855"],"confidence":"High","gaps":["Direct cardiac NCC target genes not all defined","Oncogenic target network beyond Bcl-2 not yet mapped"]},{"year":2007,"claim":"Built out the oncogenic effector network and showed dynamic RA/PcG epigenetic control of the HOXA1 locus.","evidence":"Microarray profiling, MEK1 inhibitor epistasis, E-cadherin/Rac1 perturbation in mammary cells, and time-resolved ChIP at the Hoxa1 RARE","pmids":["17213808","16373333","17663992"],"confidence":"Medium","gaps":["Direct vs indirect status of GRB2/MEK1/SDFR1 induction not fully resolved","Single-lab cancer cell line context limits generality"]},{"year":2011,"claim":"Defined epigenetic activators of HOXA1 and expanded its developmental target catalog and fate map.","evidence":"KDM3A siRNA and H3K9me2 ChIP at the promoter, microdissected r3-r5 microarray, Hoxa1-IRES-Cre fate mapping, and hexapeptide mutagenesis in cancer cells","pmids":["22020899","21784065","20171203","21957483"],"confidence":"Medium","gaps":["Whether developmental targets are direct binding events not all tested","Link between KDM3A regulation and physiological HOXA1 contexts unclear"]},{"year":2014,"claim":"Connected upstream kinase signaling to HOXA1 epigenetic activation, showing ACK1 phosphorylates KDM3A to relieve H3K9me2 repression.","evidence":"In vitro kinase assay, histone-mark ChIP, and ACK1 inhibitor (AIM-100/Dasatinib) treatment in breast cancer cells","pmids":["25148682"],"confidence":"High","gaps":["Single-lab data; physiological relevance beyond breast cancer untested","Other KDM3A substrate/locus consequences not addressed"]},{"year":2016,"claim":"Revealed a non-transcriptional signaling function for HOXA1, showing it binds RBCK1 and TRAF2 to activate NF-kappaB upstream of IkappaB.","evidence":"Proteome-wide interaction screen, Co-IP, domain-deletion mutagenesis, NF-kappaB reporter assays and RBCK1/TRAF2 epistasis","pmids":["27382069"],"confidence":"High","gaps":["Single-lab Co-IP without reciprocal in vivo validation","Subcellular site of HOXA1-NF-kappaB activation not fully resolved"]},{"year":2017,"claim":"Mapped HOXA1 genome-wide binding, establishing it as a regulator of pluripotency (mutual repression with Nanog) and multiple signaling pathways during differentiation.","evidence":"Hoxa1 and Nanog ChIP-seq in RA-differentiated ES cells, gain/loss transcriptomics in mouse and zebrafish, and in vivo enhancer reporter validation","pmids":["28584089","28982536"],"confidence":"High","gaps":["Which binding events are functionally driving vs bystander not fully separated","Direct cofactor requirements at genome-wide sites not defined"]},{"year":2019,"claim":"Resolved long-range cis-regulation of HOXA1 by demonstrating a ~450 kb distal enhancer engages the promoter via chromatin looping to enable RA-induced expression and differentiation.","evidence":"CRISPR enhancer deletion, 3C chromatin loop analysis, rescue transcriptomics, and Hoxa1 ChIP at rescued gene promoters","pmids":["31147716"],"confidence":"High","gaps":["Only ~18% of rescued gene promoters were directly bound, leaving indirect mechanisms unexplained","Single-lab ES-cell context"]},{"year":2023,"claim":"Extended HOXA1 oncogenic and pathological transcriptional output to vascular inflammation and tumor metabolism via direct activation of RelA/KLF4 and ENO1/PGK1.","evidence":"AAV-shHOXA1 in ApoE-/- atherosclerosis mice with ChIP, and reporter/knockdown/xenograft assays in cervical cancer","pmids":["37528397","37286120"],"confidence":"Medium","gaps":["Single-lab disease-model findings not independently replicated","Whether these targets are context-specific or general HOXA1 targets unclear"]},{"year":null,"claim":"How HOXA1's dual roles as a positional developmental transcription factor and a non-transcriptional NF-kappaB activator are integrated, and what determines its switch between developmental and oncogenic target programs, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of HOXA1-PBX1 on its in vivo enhancers","Mechanism selecting transcriptional vs cytoplasmic signaling functions unknown","Direct human Mendelian phenotype not established in this corpus"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[5,7,31,32,36,37]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[7,9,14,31]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[30]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[7,31,39]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[25,30]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,5,15,23]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[7,31,32]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[30,32,36]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[16,36,37]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[19,21,27,34,35]}],"complexes":[],"partners":["PBX1","RBCK1","TRAF2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P49639","full_name":"Homeobox protein Hox-A1","aliases":["Homeobox protein Hox-1F"],"length_aa":335,"mass_kda":36.7,"function":"Sequence-specific transcription factor (By similarity). Regulates multiple developmental processes including brainstem, inner and outer ear, abducens nerve and cardiovascular development and morphogenesis as well as cognition and behavior (PubMed:16155570). Also part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Acts on the anterior body structures. Seems to act in the maintenance and/or generation of hindbrain segments (By similarity). Activates transcription in the presence of PBX1A and PKNOX1 (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P49639/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HOXA1","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HOXA1","total_profiled":1310},"omim":[{"mim_id":"620163","title":"ZFP14 ZINC FINGER PROTEIN; ZFP14","url":"https://www.omim.org/entry/620163"},{"mim_id":"618813","title":"TUBULIN TYROSINE LIGASE-LIKE 7; TTLL7","url":"https://www.omim.org/entry/618813"},{"mim_id":"617649","title":"UBIQUITIN-CONJUGATING ENZYME E2 O; UBE2O","url":"https://www.omim.org/entry/617649"},{"mim_id":"617346","title":"ATP/GTP-BINDING PROTEIN-LIKE 3; AGBL3","url":"https://www.omim.org/entry/617346"},{"mim_id":"617041","title":"DUANE RETRACTION SYNDROME 3 WITH OR WITHOUT DEAFNESS; DURS3","url":"https://www.omim.org/entry/617041"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"urinary bladder","ntpm":5.0}],"url":"https://www.proteinatlas.org/search/HOXA1"},"hgnc":{"alias_symbol":[],"prev_symbol":["HOX1F","HOX1"]},"alphafold":{"accession":"P49639","domains":[{"cath_id":"1.10.10.60","chopping":"237-292","consensus_level":"medium","plddt":96.5784,"start":237,"end":292}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P49639","model_url":"https://alphafold.ebi.ac.uk/files/AF-P49639-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P49639-F1-predicted_aligned_error_v6.png","plddt_mean":57.78},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HOXA1","jax_strain_url":"https://www.jax.org/strain/search?query=HOXA1"},"sequence":{"accession":"P49639","fasta_url":"https://rest.uniprot.org/uniprotkb/P49639.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P49639/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P49639"}},"corpus_meta":[{"pmid":"8287791","id":"PMC_8287791","title":"Two rhombomeres are altered in Hoxa-1 mutant mice.","date":"1993","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8287791","citation_count":362,"is_preprint":false},{"pmid":"7903632","id":"PMC_7903632","title":"Loss of Hox-A1 (Hox-1.6) function results in the reorganization of the murine hindbrain.","date":"1993","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7903632","citation_count":309,"is_preprint":false},{"pmid":"9053316","id":"PMC_9053316","title":"In vivo functional analysis of the Hoxa-1 3' retinoic acid response element (3'RARE).","date":"1997","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9053316","citation_count":289,"is_preprint":false},{"pmid":"9463359","id":"PMC_9463359","title":"Hoxa1 and Hoxb1 synergize in patterning the hindbrain, cranial nerves and second pharyngeal arch.","date":"1998","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9463359","citation_count":261,"is_preprint":false},{"pmid":"9463349","id":"PMC_9463349","title":"Genetic interactions between Hoxa1 and Hoxb1 reveal new roles in regulation of early hindbrain patterning.","date":"1998","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9463349","citation_count":252,"is_preprint":false},{"pmid":"16155570","id":"PMC_16155570","title":"Homozygous HOXA1 mutations disrupt human brainstem, inner ear, cardiovascular and cognitive development.","date":"2005","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16155570","citation_count":214,"is_preprint":false},{"pmid":"7743939","id":"PMC_7743939","title":"Evolutionary-conserved enhancers direct region-specific expression of the murine Hoxa-1 and Hoxa-2 loci in both mice and Drosophila.","date":"1995","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7743939","citation_count":185,"is_preprint":false},{"pmid":"10529420","id":"PMC_10529420","title":"Mice mutant for both Hoxa1 and Hoxb1 show extensive remodeling of the hindbrain and defects in craniofacial development.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10529420","citation_count":163,"is_preprint":false},{"pmid":"8631251","id":"PMC_8631251","title":"Ectopic expression of Hoxa-1 in the zebrafish alters the fate of the mandibular arch neural crest and phenocopies a retinoic acid-induced phenotype.","date":"1996","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8631251","citation_count":162,"is_preprint":false},{"pmid":"7956823","id":"PMC_7956823","title":"Ectopic Hoxa-1 induces rhombomere transformation in mouse hindbrain.","date":"1994","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7956823","citation_count":152,"is_preprint":false},{"pmid":"8105479","id":"PMC_8105479","title":"Loss of retinoic acid receptor gamma function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8105479","citation_count":150,"is_preprint":false},{"pmid":"10662633","id":"PMC_10662633","title":"Roles of Hoxa1 and Hoxa2 in patterning the early hindbrain of the mouse.","date":"2000","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10662633","citation_count":141,"is_preprint":false},{"pmid":"30376874","id":"PMC_30376874","title":"Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.","date":"2018","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/30376874","citation_count":138,"is_preprint":false},{"pmid":"12482855","id":"PMC_12482855","title":"Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12482855","citation_count":127,"is_preprint":false},{"pmid":"17663992","id":"PMC_17663992","title":"Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARbeta(2), and Cyp26A1 in F9 embryonal carcinoma cells.","date":"2007","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17663992","citation_count":112,"is_preprint":false},{"pmid":"23723417","id":"PMC_23723417","title":"linc-HOXA1 is a noncoding RNA that represses Hoxa1 transcription in cis.","date":"2013","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/23723417","citation_count":111,"is_preprint":false},{"pmid":"11091361","id":"PMC_11091361","title":"Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders.","date":"2000","source":"Teratology","url":"https://pubmed.ncbi.nlm.nih.gov/11091361","citation_count":110,"is_preprint":false},{"pmid":"8650243","id":"PMC_8650243","title":"Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RAR beta 2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8650243","citation_count":105,"is_preprint":false},{"pmid":"24559685","id":"PMC_24559685","title":"Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100.","date":"2014","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/24559685","citation_count":103,"is_preprint":false},{"pmid":"29662483","id":"PMC_29662483","title":"Long Non-Coding RNA HOXA Transcript Antisense RNA Myeloid-Specific 1-HOXA1 Axis Downregulates the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in Lung Cancer.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29662483","citation_count":97,"is_preprint":false},{"pmid":"7851655","id":"PMC_7851655","title":"Regulation of the Xenopus labial homeodomain genes, HoxA1 and HoxD1: activation by retinoids and peptide growth factors.","date":"1995","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/7851655","citation_count":97,"is_preprint":false},{"pmid":"26707824","id":"PMC_26707824","title":"Long noncoding RNA-HOTAIR affects chemoresistance by regulating HOXA1 methylation in small cell lung cancer cells.","date":"2015","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26707824","citation_count":94,"is_preprint":false},{"pmid":"14522873","id":"PMC_14522873","title":"Neuronal defects in the hindbrain of Hoxa1, Hoxb1 and Hoxb2 mutants reflect regulatory interactions among these Hox genes.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/14522873","citation_count":94,"is_preprint":false},{"pmid":"22407312","id":"PMC_22407312","title":"MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.","date":"2012","source":"Annals of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22407312","citation_count":94,"is_preprint":false},{"pmid":"9733765","id":"PMC_9733765","title":"An enhancer element in the EphA2 (Eck) gene sufficient for rhombomere-specific expression is activated by HOXA1 and HOXB1 homeobox proteins.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9733765","citation_count":91,"is_preprint":false},{"pmid":"11532923","id":"PMC_11532923","title":"Synergy between Hoxa1 and Hoxb1: the relationship between arch patterning and the generation of cranial neural crest.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11532923","citation_count":90,"is_preprint":false},{"pmid":"22020899","id":"PMC_22020899","title":"The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene.","date":"2011","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22020899","citation_count":79,"is_preprint":false},{"pmid":"18412118","id":"PMC_18412118","title":"The clinical spectrum of homozygous HOXA1 mutations.","date":"2008","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/18412118","citation_count":79,"is_preprint":false},{"pmid":"29228867","id":"PMC_29228867","title":"Long non-coding RNA CCAT1 promotes multiple myeloma progression by acting as a molecular sponge of miR-181a-5p to modulate HOXA1 expression.","date":"2018","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/29228867","citation_count":78,"is_preprint":false},{"pmid":"21940751","id":"PMC_21940751","title":"Cardiovascular defects in a mouse model of HOXA1 syndrome.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21940751","citation_count":76,"is_preprint":false},{"pmid":"7917011","id":"PMC_7917011","title":"Characterization of Pax-6 and Hoxa-1 binding to the promoter region of the neural cell adhesion molecule L1.","date":"1994","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7917011","citation_count":76,"is_preprint":false},{"pmid":"11466434","id":"PMC_11466434","title":"Generation of a novel functional neuronal circuit in Hoxa1 mutant mice.","date":"2001","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11466434","citation_count":71,"is_preprint":false},{"pmid":"10529419","id":"PMC_10529419","title":"Compensatory defects associated with mutations in Hoxa1 restore normal palatogenesis to Hoxa2 mutants.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10529419","citation_count":68,"is_preprint":false},{"pmid":"24382894","id":"PMC_24382894","title":"Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice.","date":"2014","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24382894","citation_count":67,"is_preprint":false},{"pmid":"27382069","id":"PMC_27382069","title":"HOXA1 binds RBCK1/HOIL-1 and TRAF2 and modulates the TNF/NF-κB pathway in a transcription-independent manner.","date":"2016","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/27382069","citation_count":62,"is_preprint":false},{"pmid":"14960295","id":"PMC_14960295","title":"Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism.","date":"2004","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/14960295","citation_count":62,"is_preprint":false},{"pmid":"17875913","id":"PMC_17875913","title":"Clinical characterization of the HOXA1 syndrome BSAS variant.","date":"2007","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17875913","citation_count":61,"is_preprint":false},{"pmid":"8670198","id":"PMC_8670198","title":"Detection of HOXA1 expression in human breast cancer.","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8670198","citation_count":59,"is_preprint":false},{"pmid":"25148682","id":"PMC_25148682","title":"ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25148682","citation_count":58,"is_preprint":false},{"pmid":"9806922","id":"PMC_9806922","title":"Hoxa1 and Krox-20 synergize to control the development of rhombomere 3.","date":"1998","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9806922","citation_count":57,"is_preprint":false},{"pmid":"17213808","id":"PMC_17213808","title":"HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17213808","citation_count":56,"is_preprint":false},{"pmid":"30731321","id":"PMC_30731321","title":"miR-10a-5p Promotes Chondrocyte Apoptosis in Osteoarthritis by Targeting HOXA1.","date":"2018","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/30731321","citation_count":56,"is_preprint":false},{"pmid":"26135141","id":"PMC_26135141","title":"HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells.","date":"2015","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/26135141","citation_count":54,"is_preprint":false},{"pmid":"11278854","id":"PMC_11278854","title":"The recruitment of SOX/OCT complexes and the differential activity of HOXA1 and HOXB1 modulate the Hoxb1 auto-regulatory enhancer function.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278854","citation_count":53,"is_preprint":false},{"pmid":"26417931","id":"PMC_26417931","title":"MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26417931","citation_count":51,"is_preprint":false},{"pmid":"20171203","id":"PMC_20171203","title":"Hoxa1 lineage tracing indicates a direct role for Hoxa1 in the development of the inner ear, the heart, and the third rhombomere.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20171203","citation_count":51,"is_preprint":false},{"pmid":"21784065","id":"PMC_21784065","title":"Identification of novel Hoxa1 downstream targets regulating hindbrain, neural crest and inner ear development.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21784065","citation_count":48,"is_preprint":false},{"pmid":"30596070","id":"PMC_30596070","title":"H3K27me3 induces multidrug resistance in small cell lung cancer by affecting HOXA1 DNA methylation via regulation of the lncRNA HOTAIR.","date":"2018","source":"Annals of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30596070","citation_count":48,"is_preprint":false},{"pmid":"9620166","id":"PMC_9620166","title":"Expression of Hoxa-1 and Hoxb-7 is regulated by extracellular matrix-dependent signals in mammary epithelial cells.","date":"1998","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9620166","citation_count":48,"is_preprint":false},{"pmid":"26284287","id":"PMC_26284287","title":"Hoxb1 regulates proliferation and differentiation of second heart field progenitors in pharyngeal mesoderm and genetically interacts with Hoxa1 during cardiac outflow tract development.","date":"2015","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/26284287","citation_count":46,"is_preprint":false},{"pmid":"28584089","id":"PMC_28584089","title":"Dynamic regulation of Nanog and stem cell-signaling pathways by Hoxa1 during early neuro-ectodermal differentiation of ES cells.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28584089","citation_count":45,"is_preprint":false},{"pmid":"30896864","id":"PMC_30896864","title":"circEIF4G2 modulates the malignant features of cervical cancer via the miR‑218/HOXA1 pathway.","date":"2019","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/30896864","citation_count":45,"is_preprint":false},{"pmid":"32284737","id":"PMC_32284737","title":"The LncRNA HOTAIRM1 Promotes Tamoxifen Resistance by Mediating HOXA1 Expression in ER+ Breast Cancer Cells.","date":"2020","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32284737","citation_count":43,"is_preprint":false},{"pmid":"23088713","id":"PMC_23088713","title":"Protein interactions of the transcription factor Hoxa1.","date":"2012","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23088713","citation_count":42,"is_preprint":false},{"pmid":"32163893","id":"PMC_32163893","title":"lncRNA NEAT1 Binds to MiR-339-5p to Increase HOXA1 and Alleviate Ischemic Brain Damage in Neonatal Mice.","date":"2020","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/32163893","citation_count":39,"is_preprint":false},{"pmid":"32084702","id":"PMC_32084702","title":"lncRNA CCAT1 Acts as a MicroRNA-218 Sponge to Increase Gefitinib Resistance in NSCLC by Targeting HOXA1.","date":"2020","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/32084702","citation_count":39,"is_preprint":false},{"pmid":"16373333","id":"PMC_16373333","title":"HOXA1 is required for E-cadherin-dependent anchorage-independent survival of human mammary carcinoma cells.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16373333","citation_count":38,"is_preprint":false},{"pmid":"28982536","id":"PMC_28982536","title":"Hoxa1 targets signaling pathways during neural differentiation of ES cells and mouse embryogenesis.","date":"2017","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28982536","citation_count":38,"is_preprint":false},{"pmid":"25691658","id":"PMC_25691658","title":"YAP regulates the expression of Hoxa1 and Hoxc13 in mouse and human oral and skin epithelial tissues.","date":"2015","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25691658","citation_count":36,"is_preprint":false},{"pmid":"16989981","id":"PMC_16989981","title":"Induction of the homeotic gene Hoxa1 through valproic acid's teratogenic mechanism of action.","date":"2006","source":"Neurotoxicology and teratology","url":"https://pubmed.ncbi.nlm.nih.gov/16989981","citation_count":36,"is_preprint":false},{"pmid":"31853186","id":"PMC_31853186","title":"LncRNA HOTAIRM1/HOXA1 Axis Promotes Cell Proliferation, Migration And Invasion In Endometrial Cancer.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31853186","citation_count":35,"is_preprint":false},{"pmid":"11840501","id":"PMC_11840501","title":"Lack of association between HoxA1 and HoxB1 gene variants and autism in 110 multiplex families.","date":"2002","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11840501","citation_count":32,"is_preprint":false},{"pmid":"7488013","id":"PMC_7488013","title":"Retinoic acid induces three newly cloned HOXA1 transcripts in MCF7 breast cancer cells.","date":"1995","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/7488013","citation_count":32,"is_preprint":false},{"pmid":"18512762","id":"PMC_18512762","title":"Hoxa1 is required for the retinoic acid-induced differentiation of embryonic stem cells into neurons.","date":"2008","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/18512762","citation_count":31,"is_preprint":false},{"pmid":"33230449","id":"PMC_33230449","title":"lncRNA HotairM1 Depletion Promotes Self-Renewal of Cancer Stem Cells through HOXA1-Nanog Regulation Loop.","date":"2020","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/33230449","citation_count":31,"is_preprint":false},{"pmid":"33328510","id":"PMC_33328510","title":"LncRNA HOTAIRM1 promotes MDSC expansion and suppressive functions through the HOXA1-miR124 axis during HCV infection.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33328510","citation_count":30,"is_preprint":false},{"pmid":"28540746","id":"PMC_28540746","title":"KDM3B shows tumor-suppressive activity and transcriptionally regulates HOXA1 through retinoic acid response elements in acute myeloid leukemia.","date":"2017","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/28540746","citation_count":30,"is_preprint":false},{"pmid":"12412013","id":"PMC_12412013","title":"Targeted insertion results in a rhombomere 2-specific Hoxa2 knockdown and ectopic activation of Hoxa1 expression.","date":"2002","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/12412013","citation_count":30,"is_preprint":false},{"pmid":"12060683","id":"PMC_12060683","title":"Changing homeodomain residues 2 and 3 of Hoxa1 alters its activity in a cell-type and enhancer dependent manner.","date":"2002","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/12060683","citation_count":28,"is_preprint":false},{"pmid":"9582372","id":"PMC_9582372","title":"A conserved C-terminal domain in PBX increases DNA binding by the PBX homeodomain and is not a primary site of contact for the YPWM motif of HOXA1.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9582372","citation_count":28,"is_preprint":false},{"pmid":"37528397","id":"PMC_37528397","title":"HOXA1 participates in VSMC-to-macrophage-like cell transformation via regulation of NF-κB p65 and KLF4: a potential mechanism of atherosclerosis pathogenesis.","date":"2023","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/37528397","citation_count":27,"is_preprint":false},{"pmid":"32364673","id":"PMC_32364673","title":"microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.","date":"2020","source":"Thoracic cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32364673","citation_count":27,"is_preprint":false},{"pmid":"27956219","id":"PMC_27956219","title":"Hoxa1 and Hoxb1 are required for pharyngeal arch artery development.","date":"2016","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/27956219","citation_count":26,"is_preprint":false},{"pmid":"37286120","id":"PMC_37286120","title":"HOXA1 promotes aerobic glycolysis and cancer progression in cervical cancer.","date":"2023","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/37286120","citation_count":25,"is_preprint":false},{"pmid":"32561925","id":"PMC_32561925","title":"Long Noncoding RNA ZFPM2-AS1 Knockdown Restrains the Development of Retinoblastoma by Modulating the MicroRNA-515/HOXA1/Wnt/β-Catenin Axis.","date":"2020","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/32561925","citation_count":25,"is_preprint":false},{"pmid":"32497022","id":"PMC_32497022","title":"Long non-coding RNA SNHG1 activates HOXA1 expression via sponging miR-193a-5p in breast cancer progression.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/32497022","citation_count":23,"is_preprint":false},{"pmid":"33520978","id":"PMC_33520978","title":"Tumor-Suppressive Role of microRNA-202-3p in Hepatocellular Carcinoma Through the KDM3A/HOXA1/MEIS3 Pathway.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33520978","citation_count":23,"is_preprint":false},{"pmid":"33048872","id":"PMC_33048872","title":"Long noncoding RNA HOTAIRM1 promotes myeloid-derived suppressor cell expansion and suppressive functions through up-regulating HOXA1 expression during latent HIV infection.","date":"2020","source":"AIDS (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/33048872","citation_count":21,"is_preprint":false},{"pmid":"21957483","id":"PMC_21957483","title":"The Pbx interaction motif of Hoxa1 is essential for its oncogenic activity.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21957483","citation_count":21,"is_preprint":false},{"pmid":"33332731","id":"PMC_33332731","title":"MiR-10a-5p restrains the aggressive phenotypes of ovarian cancer cells by inhibiting HOXA1.","date":"2020","source":"The Kaohsiung journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33332731","citation_count":21,"is_preprint":false},{"pmid":"23064471","id":"PMC_23064471","title":"The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells.","date":"2012","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23064471","citation_count":20,"is_preprint":false},{"pmid":"28228659","id":"PMC_28228659","title":"MiR-99a suppresses cell invasion and metastasis in nasopharyngeal carcinoma through targeting HOXA1.","date":"2017","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/28228659","citation_count":20,"is_preprint":false},{"pmid":"9438427","id":"PMC_9438427","title":"An evolutionary conserved element is essential for somite and adjacent mesenchymal expression of the Hoxa1 gene.","date":"1998","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/9438427","citation_count":20,"is_preprint":false},{"pmid":"17171652","id":"PMC_17171652","title":"HOXA1 gene variants influence head growth rates in humans.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17171652","citation_count":20,"is_preprint":false},{"pmid":"32021301","id":"PMC_32021301","title":"miR-100 Inhibits Cell Growth and Proliferation by Targeting HOXA1 in Nasopharyngeal Carcinoma.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32021301","citation_count":19,"is_preprint":false},{"pmid":"23534758","id":"PMC_23534758","title":"Let-7c inhibits NSCLC cell proliferation by targeting HOXA1.","date":"2013","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/23534758","citation_count":19,"is_preprint":false},{"pmid":"35018436","id":"PMC_35018436","title":"Elevated lncRNA-UCA1 upregulates EZH2 to promote inflammatory response in sepsis-induced pneumonia via inhibiting HOXA1.","date":"2022","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/35018436","citation_count":19,"is_preprint":false},{"pmid":"26035869","id":"PMC_26035869","title":"Understanding the molecular mechanisms of human microtia via a pig model of HOXA1 syndrome.","date":"2015","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/26035869","citation_count":19,"is_preprint":false},{"pmid":"35675857","id":"PMC_35675857","title":"HOXA1, a breast cancer oncogene.","date":"2022","source":"Biochimica et biophysica acta. Reviews on cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35675857","citation_count":18,"is_preprint":false},{"pmid":"31114990","id":"PMC_31114990","title":"Long non-coding RNA 00152 promotes cell proliferation in cervical cancer via regulating miR-216b-5p/HOXA1 axis.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31114990","citation_count":18,"is_preprint":false},{"pmid":"31138758","id":"PMC_31138758","title":"Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1.","date":"2019","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/31138758","citation_count":18,"is_preprint":false},{"pmid":"30320894","id":"PMC_30320894","title":"Downregulation of microRNA-1469 promotes the development of breast cancer via targeting HOXA1 and activating PTEN/PI3K/AKT and Wnt/β-catenin pathways.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30320894","citation_count":18,"is_preprint":false},{"pmid":"10942599","id":"PMC_10942599","title":"Molecular cloning and analysis of a group of genes differentially expressed in cells which overexpress the Hoxa-1 homeobox gene.","date":"2000","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/10942599","citation_count":18,"is_preprint":false},{"pmid":"31147716","id":"PMC_31147716","title":"A distal enhancer maintaining Hoxa1 expression orchestrates retinoic acid-induced early ESCs differentiation.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/31147716","citation_count":17,"is_preprint":false},{"pmid":"16168961","id":"PMC_16168961","title":"Polyhistidine tract expansions in HOXA1 result in intranuclear aggregation and increased cell death.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16168961","citation_count":17,"is_preprint":false},{"pmid":"22950449","id":"PMC_22950449","title":"Partial chromosome 7 duplication with a phenotype mimicking the HOXA1 spectrum disorder.","date":"2012","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22950449","citation_count":17,"is_preprint":false},{"pmid":"14681917","id":"PMC_14681917","title":"No association between allelic variants of HOXA1/HOXB1 and autism.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14681917","citation_count":17,"is_preprint":false},{"pmid":"31210292","id":"PMC_31210292","title":"MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31210292","citation_count":16,"is_preprint":false},{"pmid":"32013856","id":"PMC_32013856","title":"miR-18a-3p Encourages Apoptosis of Chondrocyte in Osteoarthritis via HOXA1 Pathway.","date":"2020","source":"Current molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32013856","citation_count":15,"is_preprint":false},{"pmid":"34514705","id":"PMC_34514705","title":"Silencing long non-coding RNA DLX6-AS1 or restoring microRNA-193b-3p enhances thyroid carcinoma cell autophagy and apoptosis via depressing HOXA1.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34514705","citation_count":15,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49987,"output_tokens":9901,"usd":0.149238,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20310,"output_tokens":4781,"usd":0.110537,"stage2_stop_reason":"end_turn"},"total_usd":0.259775,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"Hoxa1 null mice display loss of rhombomeres 4 and 5, absence of facial and abducens motor neurons, and abnormal neural crest migration, establishing Hoxa1 as required for specification of rhombomere identity in the developing hindbrain.\",\n      \"method\": \"Targeted gene knockout in mice with 3D reconstructions, histological analysis, and whole-mount anti-neurofilament immunostaining\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal knockout phenotype replicated by two independent labs (PMID:8287791 and PMID:7903632) with multiple morphological and molecular readouts\",\n      \"pmids\": [\"8287791\", \"7903632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"In Hoxa1 null mice, the expression of Krox-20, int-2/fgf-3, and Hoxb1 is aberrant, indicating that Hoxa1 is required upstream of these rhombomere-identity genes and for proper specification of r3–r8 cell identity and/or cell migration.\",\n      \"method\": \"In situ hybridization and carbocyanine dye injection tract tracing in Hoxa1 null mice\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function with defined molecular readout, replicated across independent knockout lines\",\n      \"pmids\": [\"7903632\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"RAR-gamma mediates retinoic acid induction of Hoxa1 in F9 embryonal carcinoma cells; targeted disruption of RARgamma abolishes RA-induced Hoxa1 expression, establishing RARgamma as the primary receptor mediating this response in this cell context.\",\n      \"method\": \"Gene disruption of both RARgamma alleles in F9 cells followed by RA treatment and gene expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined molecular phenotype, further confirmed by RAR-type-specific synthetic retinoids in PMID:8650243\",\n      \"pmids\": [\"8105479\", \"8650243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"A retinoic acid response element (RARE) within the Hoxa1 3' enhancer is required for expression in neuroepithelium caudal to rhombomere 4; point mutations in the RARE abolish this expression domain in transgenic mice, demonstrating direct RA-mediated transcriptional control of Hoxa1.\",\n      \"method\": \"Transgenic mouse reporter assays with point mutations in the RARE; in vivo enhancer analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis of a cis-regulatory element with functional in vivo validation, replicated in PMID:9053316\",\n      \"pmids\": [\"7743939\", \"9053316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Mutation of the Hoxa1 3' RARE by Cre-loxP targeting reduces early Hoxa1 expression boundary establishment, causing rhombomere and cranial nerve abnormalities similar to (but milder than) the Hoxa1 total knockout, and abolishes correct Hoxa2 expression in rhombomere 5, demonstrating that this RARE directly mediates RA-driven Hoxa1 patterning function.\",\n      \"method\": \"Cre-loxP targeted mutation of the 3'RARE in mice; phenotypic analysis of neural and cranial structures\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vivo mutagenesis of specific cis element with orthogonal phenotypic and molecular readouts\",\n      \"pmids\": [\"9053316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Ectopic widespread expression of Hoxa1 in transgenic mice induces ectopic Hoxb1 expression in rhombomere 2 and transforms select hindbrain regions toward rhombomere-4-like identity, demonstrating that Hoxa1 functions as a transcriptional regulator of Hoxb1 and a determinant of rhombomere identity.\",\n      \"method\": \"Beta-actin promoter-driven Hoxa1 transgenic mice with in situ hybridization; dual-transgenic reporter assay with Hoxb1/lacZ\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain-of-function transgenic with dual reporter validation and multiple molecular readouts\",\n      \"pmids\": [\"7956823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Overexpression of Hoxa1 mRNA in zebrafish phenocopies retinoic acid treatment, causing anterior hindbrain abnormalities, duplication of Mauthner neurons in r2, and fate changes in r2 neural crest, establishing Hoxa1 as a mediator of RA-induced anterior hindbrain patterning.\",\n      \"method\": \"Synthetic RNA injection into fertilized zebrafish eggs; exogenous RA treatment with in situ hybridization\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function in a vertebrate model with defined phenotypic readout; single lab\",\n      \"pmids\": [\"8631251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"HOXA1 (and HOXB1), together with Pbx1, bind to Hox-Pbx consensus sites in the EphA2 (Eck) enhancer and co-expression of HOXA1 or HOXB1 with Pbx1 transactivates EphA2 enhancer-dependent reporter expression in vitro; EphA2 expression is reduced in hoxa1/hoxb1 double mutant mice, establishing EphA2 as a direct transcriptional target of Hoxa1 in rhombomere 4.\",\n      \"method\": \"In vitro DNA binding assays (EMSA), reporter gene transactivation assays, transgenic mouse enhancer analysis, and analysis of double-mutant mice\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro binding + transactivation + in vivo genetic validation with multiple orthogonal methods in single study\",\n      \"pmids\": [\"9733765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Genetic analysis of Hoxa1/Hoxb1 double-null mice reveals that both genes cooperate to establish and maintain Hoxb1 expression in rhombomere 4 via auto- and para-regulatory interactions, and that the EphA2 r4 marker fails to activate in double mutants, indicating that Hoxa1 and Hoxb1 are required to initiate r4 specification.\",\n      \"method\": \"Genetic double-mutant analysis; in situ hybridization for rhombomere markers including Eph receptors\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with molecular marker readouts, replicated across two independent papers (PMID:9463349, PMID:9463359)\",\n      \"pmids\": [\"9463349\", \"9463359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The YPWM hexapeptide motif of HOXA1 is strictly required for cooperative DNA binding with PBX1 in vitro and for cooperative interaction in vivo; the GKFQ domain of PBX increases DNA binding by PBX but is not the primary contact for the HOXA1 YPWM motif; the YPWM motif contacts the PBX homeodomain.\",\n      \"method\": \"In vitro binding assays (EMSA), reporter gene assays, truncated and mutant PBX/HOX protein analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro binding with mutagenesis and in vivo reporter validation in single study\",\n      \"pmids\": [\"9582372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Hoxa1 and Hoxb1 synergize in patterning the facial (VII) through accessory (XI) cranial nerves and the second pharyngeal arch; combined loss results in involution of the second arch by E10.5, complete loss of second arch-derived structures, and external/middle ear development disruption, revealing extensive functional synergy not apparent from single mutants.\",\n      \"method\": \"Compound Hoxa1/Hoxb1 null mouse mutant analysis; neurofilament staining; retrograde motor neuron labeling; neural crest marker analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis in compound mutants with multiple orthogonal morphological and molecular readouts, replicated across labs\",\n      \"pmids\": [\"9463359\", \"10529420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"HOXB1 has significantly higher transcriptional activity than its paralog HOXA1 on the Hoxb1 auto-regulatory enhancer (b1-ARE) in embryonal carcinoma cells; this differential activity maps to the N-terminal transcriptional activation domain of HOXB1; in vivo, Hoxa1 is the primary mediator of the RA response at the b1-ARE in a SOX/OCT heterodimer-dependent manner.\",\n      \"method\": \"Reporter gene assays in embryonal carcinoma cells; domain-swap analysis; transgenic mouse analysis with SOX/OCT site mutations; Hoxa1 mutant mice\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reporter assay with domain mapping plus in vivo transgenic and mutant mouse validation in single study\",\n      \"pmids\": [\"11278854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Loss of Hoxa1 results in reduction of rhombomere 4 size and loss of its ability to generate neural crest cells, demonstrated to be cell-autonomous by grafting wild-type cells into double-mutant mouse embryo cultures.\",\n      \"method\": \"Ectoderm-specific Hoxb1 regulatory mutation combined with Hoxa1 null; molecular/lineage analysis; in vitro grafting experiments\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-autonomous demonstration by grafting plus molecular marker analysis in single study\",\n      \"pmids\": [\"11532923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"In Hoxa1 null mice, ectopic neuronal groups originating from misspecified r3-r4 levels escape apoptosis, establish a supernumerary neuronal circuit with r2 identity, and become functionally integrated into the respiratory rhythm-generating network postnatally, demonstrating that Hoxa1 normally represses this alternate neural circuit.\",\n      \"method\": \"Electrophysiological recording, anatomical analysis, molecular identity marker expression in Hoxa1 null mice\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with electrophysiological and molecular readouts, single lab\",\n      \"pmids\": [\"11466434\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Homeodomain residues 2 and 3 (Asn and Ala) of Hoxa1 determine its functional specificity on the somatostatin TSEII enhancer as a monomer, but do not affect activity in HOXA1-Pbx1 heterodimers; on the Hoxb1 b1-ARE, these residues can modulate activity in a cell-type dependent manner even in the presence of Pbx.\",\n      \"method\": \"Site-directed mutagenesis of homeodomain residues; reporter gene transactivation assays in multiple cell lines with defined cofactors\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis combined with reporter assays; single lab, cell-based only\",\n      \"pmids\": [\"12060683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Hoxa1 is required upstream of several genes regulating cardiac neural crest cell specification; Hoxa1 null mice exhibit cardiovascular malformations (interrupted aortic arch, aberrant subclavian artery, Tetralogy of Fallot), and lineage tracing shows Hoxa1 is expressed in cardiac NCC precursors.\",\n      \"method\": \"Hoxa1-IRES-Cre lineage tracing; Hoxa1 null mouse cardiovascular phenotyping; molecular marker analysis for NCC specification genes\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — lineage tracing combined with loss-of-function phenotyping and upstream/downstream gene analysis; replicated in human syndrome (PMID:16155570)\",\n      \"pmids\": [\"21940751\", \"20171203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"HOXA1 transcriptionally upregulates Bcl-2, promoting cell survival in human mammary carcinoma cells; forced HOXA1 expression also promotes anchorage-independent proliferation and induces oncogenic transformation of immortalized mammary epithelial cells in a Bcl-2-dependent manner.\",\n      \"method\": \"Forced expression and siRNA knockdown of HOXA1 in human mammary carcinoma cells; luciferase reporter assays; soft-agar colony formation; in vivo tumor formation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional rescue/inhibition with defined molecular target; single lab\",\n      \"pmids\": [\"12482855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"E-cadherin-dependent signaling via Rac1 increases HOXA1 expression at confluence in mammary carcinoma cells, and this HOXA1 upregulation is required for E-cadherin-dependent anchorage-independent proliferation and survival.\",\n      \"method\": \"E-cadherin function-blocking antibody, Ca2+ chelation with EGTA, Rac1 pathway analysis, HOXA1 forced expression and siRNA in MCF-7 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple epistatic and pharmacological perturbations; single lab\",\n      \"pmids\": [\"16373333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HOXA1-stimulated oncogenicity in human mammary carcinoma cells is mediated by transcriptional upregulation of GRB2, MEK1, and SDFR1, leading to increased p44/42 MAP kinase phosphorylation and activity; MEK1 inhibitor abolishes HOXA1-mediated proliferation, survival, and transformation.\",\n      \"method\": \"Microarray gene expression profiling; Western blot for phospho-MAPK; MEK1 inhibitor treatment; forced HOXA1 expression and siRNA knockdown\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional epistasis with pharmacological inhibitor and multiple molecular readouts; single lab\",\n      \"pmids\": [\"17213808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RARgamma and RXRalpha are constitutively associated with the Hoxa1 RARE; upon RA treatment, pCIP, p300, and RNA Pol II increase at the Hoxa1 RARE while the PcG protein SUZ12 dissociates; H3K27me3 decreases while H3ac and H3K4me2 remain constant; upon RA removal, SUZ12 re-associates, revealing dynamic epigenetic regulation of Hoxa1 by RA signaling and PcG repression.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) assays in F9 embryonal carcinoma cells for RAR, RXR, co-activators, Pol II, SUZ12, and histone modifications\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with multiple antibodies and time-points; single lab\",\n      \"pmids\": [\"17663992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Hoxa1 is required for neuronal differentiation of ES cells along the neural lineage in response to RA; Hoxa1 null ES cells fail to express neuronal markers and instead upregulate endodermal markers; re-introduction of Hoxa1 rescues neuronal differentiation; Hoxa1 may act partly by inhibiting Sox17 expression.\",\n      \"method\": \"Hoxa1 null ES cell differentiation assay; RA-induced embryoid body protocol; re-expression of exogenous Hoxa1 under metallothionein promoter; Sox17 overexpression in WT ES cells\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function and rescue experiments with defined molecular readouts; single lab\",\n      \"pmids\": [\"18512762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"KDM3A (JMJD1A) activates HOXA1 transcription by demethylating histone H3K9me2 at the HOXA1 promoter; KDM3A knockdown decreases HOXA1 and CCND1 expression and causes G1 arrest; KDM3A and HOXA1 expression levels are statistically correlated in cancer cell lines and bladder cancer samples.\",\n      \"method\": \"siRNA knockdown of KDM3A; ChIP for H3K9me2 at HOXA1 promoter; gene expression analysis; cell proliferation assays\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating epigenetic writer activity at HOXA1 locus combined with functional siRNA; single lab\",\n      \"pmids\": [\"22020899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Hoxa1 null microarray analysis identifies ~300 downstream targets in the r3-r5 hindbrain region; validated targets include neural crest specification genes Zic1, Hnf1b, Foxd3 (downregulated in cardiac NCC-generating hindbrain), and inner ear genes Pax8 and Fgfr3, establishing Hoxa1 as an upstream regulator in these developmental cascades.\",\n      \"method\": \"Microarray analysis on laser-microdissected r3-r5 tissue from Hoxa1 null vs. wild-type embryos; RT-PCR validation\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with validated gene expression changes in tissue-specific context; single lab\",\n      \"pmids\": [\"21784065\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Hoxa1 lineage tracing via Hoxa1-IRES-Cre reveals Hoxa1-expressing precursors contribute to rhombomere 3 (more anterior than previously reported), otic epithelium (excluding sensory patches), atria, and cardiac outflow tract, indicating a direct role for Hoxa1 in these tissues.\",\n      \"method\": \"Genetic lineage tracing using Hoxa1-IRES-Cre knock-in mouse line with Rosa26-reporter\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct genetic fate mapping with functional implications; single lab but rigorous method\",\n      \"pmids\": [\"20171203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The Pbx-interaction hexapeptide (YPWM-containing) motif of Hoxa1 is essential for its oncogenic activity; a Hoxa1 mutant with substituted hexapeptide residues loses the ability to stimulate cell proliferation, anchorage-independent growth, and contact inhibition bypass.\",\n      \"method\": \"Site-directed mutagenesis of the hexapeptide; forced expression of wild-type vs. mutant Hoxa1 in mammary carcinoma cells; proliferation, soft-agar, and contact inhibition assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional mutagenesis with defined oncogenic phenotype readout; single lab\",\n      \"pmids\": [\"21957483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A proteome-wide yeast two-hybrid screen and affinity co-purification identified 59 Hoxa1 interactors (45 confirmed by co-purification), including cell-signaling, cell-adhesion, and vesicular trafficking proteins; bimolecular fluorescence complementation revealed distinctive subcellular patterns (vesicular, cytoplasmic, or nuclear) for different interaction subsets.\",\n      \"method\": \"Yeast two-hybrid screening of ~12,200 ORF-derived polypeptides; affinity co-purification in animal cell lines; bimolecular fluorescence complementation\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic interactome screen confirmed by co-purification and BiFC; pan-interactome format but focused on this gene\",\n      \"pmids\": [\"23088713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HOXA1 increases PRLR (prolactin receptor) mRNA and protein expression in MCF-7 cells; forced HOXA1 expression enhances prolactin-stimulated phosphorylation of STAT5A/B and p44/42 MAPK and enhances hPRL-stimulated cell proliferation and anchorage-independent growth, which is blocked by a PRLR antagonist, establishing PRLR as a functional downstream effector of HOXA1 oncogenicity.\",\n      \"method\": \"Forced HOXA1 expression in MCF-7 cells; PRLR mRNA/protein quantification; phosphorylation assays; PRLR antagonist; soft-agar growth assay\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — forced expression with pharmacological epistasis and multiple signaling readouts; single lab\",\n      \"pmids\": [\"23064471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ACK1 tyrosine kinase phosphorylates the H3K9 demethylase KDM3A at Tyr-1114 in response to heregulin, decreasing H3K9me2 deposition and thereby activating HOXA1 transcription; ACK1 inhibition by AIM-100 or Dasatinib restores H3K9me2 marks and suppresses HOXA1 expression, even in tamoxifen-resistant conditions.\",\n      \"method\": \"Kinase assay demonstrating ACK1 phosphorylation of KDM3A; histone methylation ChIP; gene expression analysis; ACK1 small molecule inhibitors in breast cancer cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct kinase-substrate phosphorylation demonstrated with histone ChIP evidence and pharmacological validation; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"25148682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"lncRNA HOTAIRM1 sequesters histone methyltransferases G9a (H3K9me2) and EZH2 (H3K27me3) and DNA methyltransferases (DNMT1, DNMT3b) away from the HOXA1 gene TSS, causing demethylation of H3K9 and H3K27 and reduced DNA methylation, thereby activating HOXA1 transcription in glioblastoma cells.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP); RNA-ChIP; bisulfite sequencing methylation analysis; siRNA knockdown of HOTAIRM1\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and RNA-ChIP with multiple histone marks plus methylation sequencing; single lab\",\n      \"pmids\": [\"30376874\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"YAP (Hippo pathway transcriptional co-activator) regulates Hoxa1 expression in dental/oral epithelium and skin epidermis; ChIP assay suggests YAP acts through TEAD transcription factors to activate Hoxa1; Hoxa1 is functionally involved in YAP-regulated epithelial progenitor cell proliferation by sphere formation assay.\",\n      \"method\": \"Yap conditional knockout and YAP transgenic mice; RNA-Seq; ChIP for YAP/TEAD; sphere formation assay; in situ hybridization\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss/gain-of-function with ChIP and functional proliferation assay; single lab\",\n      \"pmids\": [\"25691658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"HOXA1 binds RBCK1/HOIL-1 and TRAF2 (TNF receptor-associated proteins) via its 11-histidine repeat and homeodomain; HOXA1 activates NF-κB in a non-transcriptional manner, acting upstream of the NF-κB inhibitor IκB; epistasis experiments show RBCK1 and TRAF2 effects on NF-κB are epistatic to HOXA1; NF-κB activation is required for HOXA1 oncogenic activity.\",\n      \"method\": \"Proteome-wide interaction screening; co-immunoprecipitation; reporter assays for NF-κB activity; domain-deletion mutagenesis; epistasis analysis with RBCK1/TRAF2 knockdown\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — interaction confirmed by Co-IP, functional epistasis, mutagenesis, and non-transcriptional mechanism established; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"27382069\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Genome-wide Hoxa1 ChIP-seq in RA-differentiated ES cells reveals dynamic binding to pluripotency regulatory targets; Hoxa1 co-occupies many sites with Nanog, including the Nanog promoter itself; Nanog binds a 3' enhancer of Hoxa1; mutual repression between Hoxa1 and Nanog provides a molecular switch between pluripotency and differentiation. Hoxa1 also binds regulatory regions of Sox2, Esrrb, and Myc.\",\n      \"method\": \"Genome-wide ChIP-seq for Hoxa1 and Nanog in RA-treated ES cells; gene expression analysis at multiple differentiation time-points\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide binding data with reciprocal cross-regulatory validated binding; multiple targets confirmed; single lab but rigorous methods\",\n      \"pmids\": [\"28584089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Genome-wide Hoxa1 ChIP-seq combined with differential gene expression in Hoxa1 gain- and loss-of-function mouse/zebrafish embryos identifies Hoxa1 as a regulator of multiple developmental signaling pathways (Wnt, TGF-β, Hedgehog, Hippo) by targeting multiple components within each pathway; two validated enhancers (in Dok5 and Wls1) mediate neural expression in vivo.\",\n      \"method\": \"Hoxa1 ChIP-seq in RA-differentiated mouse ES cells; microarray differential expression in Hoxa1 gain/loss-of-function mouse and zebrafish; in vivo transgenic enhancer reporter assays\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq plus gain/loss-of-function transcriptomics in two species plus in vivo enhancer validation; single lab but highly rigorous multi-modal approach\",\n      \"pmids\": [\"28982536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"KDM3B binds to the retinoic acid response element (RARE) of the HOXA1 gene (but not its promoter) and regulates HOXA1 expression; KDM3B knockdown increases H3K9me1 but decreases H3K9me2 at the RARE, modulating HOXA1 transcription in AML cells.\",\n      \"method\": \"ChIP for KDM3B and histone marks (H3K9me1, H3K9me2) at HOXA1 RARE; siRNA knockdown; Western blot; real-time PCR\",\n      \"journal\": \"Leukemia & lymphoma\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating histone demethylase binding at specific HOXA1 regulatory element; single lab\",\n      \"pmids\": [\"28540746\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A distal enhancer ~450 kb from the Hoxa1 locus interacts with the Hoxa1 promoter via a long-range chromatin loop; deletion of this enhancer significantly inhibits RA-induced Hoxa1 expression and blocks early ES cell differentiation; restoration of Hoxa1 expression rescues ~40% of differentially expressed genes, and ~18% of rescued gene promoters are directly bound by Hoxa1.\",\n      \"method\": \"CRISPR/Cas9 enhancer deletion; 3C/chromatin loop analysis; transcriptome analysis; ChIP for Hoxa1 binding at rescued gene promoters\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — enhancer deletion with chromatin loop demonstration, rescue experiments, and direct Hoxa1 ChIP; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"31147716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"lncRNA HOTAIRM1 prevents PRC2 complex (EZH2/SUZ12) binding at the HOXA1 promoter, inhibiting H3K27me3 deposition and thereby maintaining HOXA1 expression; HOTAIRM1 knockdown increases H3K27me3 at the HOXA1 promoter and reduces HOXA1 expression in tamoxifen-resistant MCF-7 cells.\",\n      \"method\": \"ChIP for EZH2, SUZ12, and H3K27me3 at HOXA1 promoter; HOTAIRM1 knockdown; RNA-immunoprecipitation for HOTAIRM1-EZH2 interaction\",\n      \"journal\": \"Journal of Cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with lncRNA knockdown demonstrating epigenetic mechanism; single lab\",\n      \"pmids\": [\"32284737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HOXA1 transcriptionally activates NF-κB RelA (p65) and KLF4 in vascular smooth muscle cells (VSMCs), promoting lipid accumulation, VSMC-to-macrophage phenotypic switching, and inflammation; HOXA1 knockdown via AAV1-shHOXA1 reduces atherosclerotic plaque formation in ApoE-/- mice.\",\n      \"method\": \"AAV-mediated shRNA knockdown of HOXA1 in ApoE-/- atherosclerosis mice; in vitro POV-PC-treated VSMC model; Western blot; ChIP for HOXA1 at RelA and KLF4 promoters\",\n      \"journal\": \"Molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo loss-of-function with ChIP demonstrating direct transcriptional targets; single lab\",\n      \"pmids\": [\"37528397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"HOXA1 directly regulates the transcriptional activity of ENO1 and PGK1 (glycolytic enzymes), promoting aerobic glycolysis and cancer progression in cervical cancer cells; HOXA1 knockdown reduces glycolysis and tumor growth in vivo.\",\n      \"method\": \"Luciferase reporter assays with ENO1/PGK1 promoters; HOXA1 overexpression and knockdown in cervical cancer cells; in vivo xenograft model with glycolysis metabolite measurement\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay for direct transcriptional targets with in vivo validation; single lab\",\n      \"pmids\": [\"37286120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HOTAIR lncRNA promotes chemoresistance in SCLC by recruiting DNMT1 and DNMT3b to methylate the HOXA1 gene promoter; HOTAIR knockdown reduces HOXA1 methylation and restores HOXA1 expression; RNA immunoprecipitation confirmed a direct interaction between HOTAIR RNA and HOXA1 locus.\",\n      \"method\": \"Bisulfite sequencing PCR; Western blot for DNMTs; RNA immunoprecipitation; HOTAIR siRNA knockdown in resistant SCLC cells\",\n      \"journal\": \"Laboratory investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNA-ChIP and bisulfite sequencing establish epigenetic mechanism; single lab\",\n      \"pmids\": [\"26707824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Polyhistidine tract expansions in HOXA1 isoform A (11 and 12 histidines) cause protein aggregation in the nucleus and increased cell death compared to normal (10) or shorter variants; aggregates are ubiquitinated and inhibited by the histidine-modifying compound DEPC.\",\n      \"method\": \"Forced expression of HOXA1 polyhistidine variants in COS-7 and SK-N-SH cells; immunofluorescence for aggregation; DEPC treatment; cell viability assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct expression of protein variants with morphological and functional readouts; single lab\",\n      \"pmids\": [\"16168961\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HOXA1 is a homeodomain transcription factor that, via its YPWM hexapeptide motif and cooperative binding with PBX1 cofactors, directly activates target genes (including EphA2, Hoxb1, ENO1, PGK1, Bcl-2, PRLR, RelA, KLF4) to control hindbrain rhombomere identity, neural crest generation and migration, inner ear and cardiovascular development, and—in pathological contexts—oncogenic transformation; its expression is directly induced by retinoic acid through RARgamma/RXRalpha binding to a 3' RARE and modulated epigenetically by KDM3A-mediated H3K9me2 demethylation (activated by ACK1 phosphorylation) and PRC2/SUZ12-mediated H3K27me3, while in the nucleus it also engages non-transcriptional signaling through RBCK1/HOIL-1 and TRAF2 to activate NF-κB upstream of IκB.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HOXA1 is a homeodomain transcription factor that acts at the top of the developmental cascade specifying hindbrain rhombomere identity, in which its loss eliminates rhombomeres 4 and 5, abolishes facial and abducens motor neurons, and disrupts neural crest migration [#0]. It establishes rhombomere identity by directly regulating the rhombomere-patterning gene network, initiating and maintaining Hoxb1 expression in rhombomere 4 through auto- and para-regulatory interactions and activating the r4 marker EphA2/Eck by binding Hox-Pbx consensus sites cooperatively with PBX1 [#5, #7, #8]. This cooperative DNA binding requires the YPWM hexapeptide motif, which contacts the PBX homeodomain [#9]. HOXA1 expression is itself a direct retinoic acid response: RARgamma mediates RA induction [#2], and a 3' RARE drives correct caudal and boundary expression in vivo, with mutation of this element phenocopying a partial knockout [#3, #4]. Beyond its r4-specifying role, HOXA1 is required cell-autonomously for neural crest generation, cardiac neural crest specification and cardiovascular morphogenesis, inner ear development, and RA-driven neuronal differentiation of ES cells, governing target cascades that include Zic1, Hnf1b, Foxd3, Pax8, and Fgfr3 [#12, #15, #20, #22]. Genome-wide binding studies show HOXA1 reciprocally cross-regulates the pluripotency factor Nanog and targets multiple components of the Wnt, TGF-beta, Hedgehog, and Hippo pathways, functioning as a switch between pluripotency and differentiation [#31, #32]. In pathological contexts HOXA1 acts as an oncogene: it transcriptionally upregulates Bcl-2, PRLR, and glycolytic enzymes ENO1 and PGK1, drives GRB2/MEK1-dependent MAPK signaling, and engages a non-transcriptional route through RBCK1/HOIL-1 and TRAF2 to activate NF-kappaB upstream of IkappaB, with both the YPWM motif and NF-kappaB activation required for transformation [#16, #24, #26, #30, #37]. Its locus is heavily controlled by chromatin and epigenetic inputs, including KDM3A/KDM3B H3K9 demethylation (the former activated by ACK1 phosphorylation), PRC2/SUZ12 H3K27me3, lncRNA-directed methylation, and a distal enhancer engaged through long-range chromatin looping [#19, #21, #27, #34].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established the core developmental requirement for HOXA1 by showing it is needed to build the posterior hindbrain, defining the process the gene controls.\",\n      \"evidence\": \"Targeted knockout in mice with 3D reconstruction and neurofilament immunostaining, plus in situ analysis of downstream patterning genes\",\n      \"pmids\": [\"8287791\", \"7903632\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the direct transcriptional targets responsible for r4/r5 loss\", \"Did not distinguish cell-autonomous from non-autonomous effects\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Identified RARgamma and a 3' RARE as the upstream signal driving HOXA1, answering how positional retinoic acid information is converted into Hoxa1 transcription.\",\n      \"evidence\": \"RARgamma allelic disruption in F9 cells and transgenic reporter/Cre-loxP mutagenesis of the 3' RARE in mice\",\n      \"pmids\": [\"8105479\", \"7743939\", \"9053316\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Additional enhancers beyond the 3' RARE not fully mapped at this stage\", \"Did not address chromatin context of RARE activation\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Demonstrated HOXA1 acts as a transcriptional determinant of rhombomere identity by showing ectopic expression imposes r4-like fate and induces Hoxb1.\",\n      \"evidence\": \"Gain-of-function transgenic mice with Hoxb1/lacZ dual reporter and in situ hybridization, with zebrafish RNA injection phenocopying RA\",\n      \"pmids\": [\"7956823\", \"8631251\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not show direct binding of HOXA1 to the Hoxb1 enhancer\", \"Mechanism of fate transformation not resolved\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined the molecular logic of HOXA1 target activation, showing cooperative PBX1 binding via the YPWM motif and direct regulation of EphA2 and Hoxb1 in r4.\",\n      \"evidence\": \"EMSA, reporter transactivation, hexapeptide/homeodomain mutagenesis, transgenic enhancer assays and Hoxa1/Hoxb1 double-mutant analysis\",\n      \"pmids\": [\"9733765\", \"9463349\", \"9463359\", \"9582372\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide direct target repertoire still unknown at this stage\", \"Did not establish how monomer vs heterodimer binding choices are made in vivo\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Refined HOXA1 functional specificity by mapping activity to homeodomain residues and the N-terminal activation domain and showing cell-autonomous requirement for neural crest generation.\",\n      \"evidence\": \"Domain-swap and homeodomain mutagenesis reporter assays, SOX/OCT site transgenics, and wild-type cell grafting into double-mutant embryos\",\n      \"pmids\": [\"11278854\", \"12060683\", \"11532923\", \"11466434\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How HOXA1 and HOXB1 achieve distinct activities in vivo despite shared targets\", \"Mechanism of apoptotic/circuit repression in null mice not molecularly defined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Extended HOXA1 function to cardiovascular and broader developmental programs and uncovered its oncogenic activity through Bcl-2-mediated survival.\",\n      \"evidence\": \"Hoxa1-IRES-Cre lineage tracing and null cardiovascular phenotyping; forced expression/siRNA and soft-agar transformation in mammary cells\",\n      \"pmids\": [\"21940751\", \"20171203\", \"12482855\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct cardiac NCC target genes not all defined\", \"Oncogenic target network beyond Bcl-2 not yet mapped\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Built out the oncogenic effector network and showed dynamic RA/PcG epigenetic control of the HOXA1 locus.\",\n      \"evidence\": \"Microarray profiling, MEK1 inhibitor epistasis, E-cadherin/Rac1 perturbation in mammary cells, and time-resolved ChIP at the Hoxa1 RARE\",\n      \"pmids\": [\"17213808\", \"16373333\", \"17663992\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect status of GRB2/MEK1/SDFR1 induction not fully resolved\", \"Single-lab cancer cell line context limits generality\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined epigenetic activators of HOXA1 and expanded its developmental target catalog and fate map.\",\n      \"evidence\": \"KDM3A siRNA and H3K9me2 ChIP at the promoter, microdissected r3-r5 microarray, Hoxa1-IRES-Cre fate mapping, and hexapeptide mutagenesis in cancer cells\",\n      \"pmids\": [\"22020899\", \"21784065\", \"20171203\", \"21957483\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether developmental targets are direct binding events not all tested\", \"Link between KDM3A regulation and physiological HOXA1 contexts unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Connected upstream kinase signaling to HOXA1 epigenetic activation, showing ACK1 phosphorylates KDM3A to relieve H3K9me2 repression.\",\n      \"evidence\": \"In vitro kinase assay, histone-mark ChIP, and ACK1 inhibitor (AIM-100/Dasatinib) treatment in breast cancer cells\",\n      \"pmids\": [\"25148682\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single-lab data; physiological relevance beyond breast cancer untested\", \"Other KDM3A substrate/locus consequences not addressed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Revealed a non-transcriptional signaling function for HOXA1, showing it binds RBCK1 and TRAF2 to activate NF-kappaB upstream of IkappaB.\",\n      \"evidence\": \"Proteome-wide interaction screen, Co-IP, domain-deletion mutagenesis, NF-kappaB reporter assays and RBCK1/TRAF2 epistasis\",\n      \"pmids\": [\"27382069\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single-lab Co-IP without reciprocal in vivo validation\", \"Subcellular site of HOXA1-NF-kappaB activation not fully resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Mapped HOXA1 genome-wide binding, establishing it as a regulator of pluripotency (mutual repression with Nanog) and multiple signaling pathways during differentiation.\",\n      \"evidence\": \"Hoxa1 and Nanog ChIP-seq in RA-differentiated ES cells, gain/loss transcriptomics in mouse and zebrafish, and in vivo enhancer reporter validation\",\n      \"pmids\": [\"28584089\", \"28982536\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which binding events are functionally driving vs bystander not fully separated\", \"Direct cofactor requirements at genome-wide sites not defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Resolved long-range cis-regulation of HOXA1 by demonstrating a ~450 kb distal enhancer engages the promoter via chromatin looping to enable RA-induced expression and differentiation.\",\n      \"evidence\": \"CRISPR enhancer deletion, 3C chromatin loop analysis, rescue transcriptomics, and Hoxa1 ChIP at rescued gene promoters\",\n      \"pmids\": [\"31147716\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Only ~18% of rescued gene promoters were directly bound, leaving indirect mechanisms unexplained\", \"Single-lab ES-cell context\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Extended HOXA1 oncogenic and pathological transcriptional output to vascular inflammation and tumor metabolism via direct activation of RelA/KLF4 and ENO1/PGK1.\",\n      \"evidence\": \"AAV-shHOXA1 in ApoE-/- atherosclerosis mice with ChIP, and reporter/knockdown/xenograft assays in cervical cancer\",\n      \"pmids\": [\"37528397\", \"37286120\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab disease-model findings not independently replicated\", \"Whether these targets are context-specific or general HOXA1 targets unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How HOXA1's dual roles as a positional developmental transcription factor and a non-transcriptional NF-kappaB activator are integrated, and what determines its switch between developmental and oncogenic target programs, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of HOXA1-PBX1 on its in vivo enhancers\", \"Mechanism selecting transcriptional vs cytoplasmic signaling functions unknown\", \"Direct human Mendelian phenotype not established in this corpus\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [5, 7, 31, 32, 36, 37]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [7, 9, 14, 31]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [30]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [7, 31, 39]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [25, 30]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 5, 15, 23]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [7, 31, 32]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [30, 32, 36]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [16, 36, 37]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [19, 21, 27, 34, 35]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PBX1\", \"RBCK1\", \"TRAF2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}